Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Slideshow
7 Mistakes in Treatment-Resistant Depression
Author(s):
Raise the dose, augment, or switch? A new study suggests we may need to give antidepressants more time to be effective.
Raise the dose, augment, or switch? A new study suggests we may need to give antidepressants more time in treatment resistant depression.
Related Videos
Insulin Is an Antidepressant: A Conversation With Roger McIntyre, MD, FRCPC
A Shift in the Way We Think About the Biology of Depression: A Conversation With John H. Krystal, MD
Potential Success With DBS: Reducing Stigma and Addressing Unmet Need
Neuroscience and Psychiatry: Mending the Schism
X Marks the Spot: Challenges for Therapeutic Target Engagement in DBS
Deep Brain Stimulation: A Pacemaker for the Brain
Upcoming Research Related to DLX-001 for Major Depressive Disorder
Why We Need a New Class of Antidepressants
Separating the Therapeutic From the Hallucinatory: A Look at a Novel Neuroplastogen for MDD
New Phase 1 Data on DLX-001 for Patients With Major Depressive Disorder
Related Content
